PersonFounderExecutive
Mike Novotny
Mike Novotny is the founder and CEO of Medrio, a San Francisco-based eClinical SaaS company he started in his apartment in 2005. Over 15 years he bootstrapped Medrio into a nine-figure company that has helped customers win regulatory approvals for more than 100 treatments. After a sabbatical researching organizational development, he returned as CEO in 2025, betting that AI will reshape clinical trial data management. Before Medrio, he was CEO of Telosa, President of Ninaza, a UN research associate, and managed the fraud database at Visa. He holds degrees from Stanford, PUC Chile, and Columbia.
clinical-trialsedclinicalsaashealth-techfounderceo